23andMe launches Health Action Plan based on genetic/health data

23andMe, the renowned genetic health and biopharmaceutical company, has introduced the Health Action Plan, an innovative digital tool tailored exclusively for 23andMe+ members. This tool leverages insights from genetic reports, health history surveys, and blood and biomarker data to offer a uniquely customised set of health recommendations from a vast array of choices.

The Health Action Plan stands as an invaluable initial step in the realm of preventive healthcare and early risk detection. It furnishes customers with specific actions and guidance to embark on their personal health journey. However, it's imperative to note that 23andMe emphasises that this tool should not replace the need for a visit to one's primary healthcare provider.

Each recommendation provided by the Health Action Plan is firmly rooted in scientific evidence and is meticulously crafted and reviewed by a team of experts, including scientists, genetic counsellors, and medical professionals at 23andMe. This digital tool amalgamates a customer's genetic health reports with their self-reported health history. This combined data serves as the foundation for crafting personalised recommendations, prioritising the most crucial steps for an individual to take. The more information a customer shares, the more refined and personalised their recommendations become.

Beyond suggestions for modifying aspects of daily life, such as sleep patterns, dietary habits, and exercise routines, the recommendations also encompass guidance on exploring potential new treatments or activities for specific conditions. Moreover, customers can enhance the personalization of their recommendations by inputting additional health data, including diagnoses and family medical history. Eligible customers may even receive recommendations for further clinical actions, like undergoing a blood test, a process that can now be seamlessly coordinated through 23andMe.

The 23andMe platform efficiently manages the testing process, offering a swift and convenient means to order, pay for, and schedule appointments at local labs. Customers can anticipate receiving their results and a personalised clinical analysis within 3-5 business days. The inclusion of biomarker data, in conjunction with genetic information, enables the identification of potential health risks, empowering individuals to take necessary actions. Furthermore, customers have the opportunity to connect with a clinician to discuss their results and gain a deeper understanding of their health insights.

Click here to read the original news story.